Ranbaxy targets
M&A for drugs growth
Posted AtNew
Kerala
Ranbaxy Laboratories Ltd is actively
pursuing a handful of acquisition opportunities in the
United States and elsewhere to boost its generics drugs
business, its new CEO said on Wednesday.
Malvinder Singh, who took over the job
at India's leading drugmaker last week, said he hoped
a deal might be clinched in 2006, adding the U.S. market
was a key priority.
January 25, 2006
Full
Story
Why outsourcing to India is
a great idea
Posted AtRediff.com
Globalization has been brutal to US's
midwestern manufacturers like the Paper Converting Machine
Co.
For decades, PCMC's Green Bay (Wis.)
factory, its oiled wooden factory floors worn smooth
by work boots, thrived by making ever-more-complex equipment
to weave, fold, and print packaging for everything from
potato chips to baby wipes.
But PCMC has fallen on hard times. First
came the 2001 recession. Then, two years ago, one of
the company's biggest customers told it to slash its
machinery prices by 40% and urged it to move production
to China. Last year, a St. Louis holding company, Barry-Wehmiller
Cos., acquired the manufacturer and promptly cut workers
and nonunion pay.
January 25, 2006
Full
Story |
